Objectives: To examine the adequacy of available evidence that: 1) left ventricular hypertrophy (LVH) and its regression influence the rate of cardiovascular events in hypertension; 2) carotid artery wall thickening and discrete plaque have comparable significance to LVH; and 3) black hypertensive patients have greater target organ damage than white hypertensives, independent of blood pressure and other relevant covariates.

Design And Methods: Statistical, epidemiologic, and treatment trial literature concerning ECG and echocardiographic LVH and carotid ultrasound findings was reviewed to address the above three questions.

Results: Results of seven electrocardiographic and ten echocardiographic studies (total of 20,000 subjects) show consistently higher risks of morbid events in individuals with LVH as compared to those without (odds ratios 1.4 to 5.4). Available data (five studies, 1544 subjects) suggest that morbid events occur in a greater proportion of individuals in whom LVH progresses (13% to 59%) than in whom it regresses (7% to 12%). Results of four studies using carotid ultrasound (n = 9570) show consistently higher rates of subsequent cardiovascular events in individuals with carotid wall thickening, discrete atherosclerotic plaque or arterial stenosis than those without; however, data are only available from one study regarding the relation between longitudinal change in carotid ultrasound findings and subsequent events. Of the available echocardiographic studies comparing black and white hypertensive patients, most (7 out of 9) show higher LV wall thickness in blacks, with no consistent difference with regard to LV mass.

Conclusions: LVH satisfies strict criteria to establish a fully adequate surrogate endpoint for morbid events in hypertension more fully than do carotid arterial findings. It has not yet been fully established whether black-white differences in hypertensive target organ damage are independent of blood pressure or other factors.

Download full-text PDF

Source

Publication Analysis

Top Keywords

target organ
12
organ damage
12
independent blood
12
carotid ultrasound
12
morbid events
12
damage independent
8
cardiovascular events
8
events hypertension
8
wall thickening
8
thickening discrete
8

Similar Publications

Introduction: Hemoperfusion (HP), a blood filtration method targeting the removal of toxins and inflammatory elements, was investigated in this study. The objective was to present the observations in four individuals with confirmed COVID-19 who underwent several rounds of HP utilizing the HA330 cartridge at a hospital in Indonesia.

Case Studies: We report four cases of COVID-19 patients who underwent HP.

View Article and Find Full Text PDF

Introduction: The core objective of this study was to precisely locate metastatic lymph nodes, identify potential areas in nasopharyngeal carcinoma patients that may not require radiotherapy, and propose a hypothesis for reduced target volume radiotherapy on the basis of these findings. Ultimately, we reassessed the differences in dosimetry of organs at risk (OARs) between reduced target volume (reduced CTV2) radiotherapy and standard radiotherapy.

Methods And Materials: A total of 209 patients participated in the study.

View Article and Find Full Text PDF

Epidemiological evidence has shown that the regular ingestion of vegetables and fruits is associated with reduced risk of developing chronic diseases. The introduction of the 3Rs (replacement, reduction, and refinement) principle into animal experiments has led to the use of valid, cost-effective, and efficient alternative and complementary invertebrate animal models which are simpler and lower in the phylogenetic hierarchy. Caenorhabditis elegans (C.

View Article and Find Full Text PDF

Pifithrin-μ sensitizes mTOR-activated liver cancer to sorafenib treatment.

Cell Death Dis

January 2025

Department of Organ Transplantation and Hepatobiliary Surgery, Key Laboratory of Organ Transplantation of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.

TSC2, a suppressor of mTOR, is inactivated in up to 20% of HBV-associated liver cancer. This subtype of liver cancer is associated with aggressive behavior and early recurrence after hepatectomy. Being the first targeted regimen for advanced liver cancer, sorafenib has limited efficacy in HBV-positive patients.

View Article and Find Full Text PDF

Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate (AEC) syndrome is a rare genetic disorder caused by mutations in the TP63 gene, which encodes a transcription factor essential for epidermal gene expression. A key feature of AEC syndrome is chronic skin erosion, for which no effective treatment currently exists. Our previous studies demonstrated that mutations associated with AEC syndrome lead to p63 protein misfolding and aggregation, exerting a dominant-negative effect.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!